08:00 , Feb 4, 2016 |  BC Innovations  |  Translation in Brief

Peanut butter fingerprints

Stanford University School of Medicine's Sean N. Parker Center for Allergy and Asthma Research was launched last year to aggressively pursue treatments with long-term benefits for severe allergies. Now, a team at the center has...
02:10 , Jun 9, 2015 |  BC Extra  |  Clinical News

Aimmune reports Phase II peanut allergy data

Aimmune Therapeutics Inc. (Brisbane, Calif.) reported results from the Phase II ARC001 study of AR101 to treat peanut allergy. The company said that all 23 patients who completed treatment with AR101 met the primary endpoint...
07:00 , Mar 16, 2015 |  BC Week In Review  |  Financial News

Allergen Research completes venture financing

Allergen Research Corp. , San Mateo, Calif.   Business: Inflammation   Date completed: 2015-03-12   Type: Venture financing   Raised: $80 million   Investors: Foresite Capital; Longitude Capital Management; Fidelity; Aisling Capital ; Adage Capital...
01:33 , Mar 13, 2015 |  BC Extra  |  Financial News

Allergen raises $80M for peanut Phase III

Allergen Research Corp. (San Mateo, Calif.) raised $80 million in a series B round led by Foresite Capital. Existing investor Longitude Capital and new investors Fidelity Management & Research Co.; Aisling Capital ; Adage Capital;...
08:00 , Nov 3, 2014 |  BC Week In Review  |  Company News

Raptor management update

Raptor Pharmaceutical Corp. (NASDAQ:RPTP), Novato, Calif.   Business: Neurology, Endocrine/Metabolic, Renal   Departed: Georgia Erbez as VP and CFO; Controller Frank Lanza becomes interim principal financial and accounting officer   Hired: David Happel as chief...
07:00 , Mar 10, 2014 |  BC Week In Review  |  Clinical News

Peanut Allergy Oral Immunotherapy: Phase IIb started

Allergen Research began a double-blind, placebo-controlled, U.S. Phase IIb trial to evaluate the company's Peanut Allergy OIT in about 55 peanut-allergic subjects ages 4-26 years. The trial will follow a slow, steady up-dosing regimen to...
08:00 , Nov 25, 2013 |  BC Week In Review  |  Financial News

Allergen Research completes venture financing

Allergen Research Corp. , San Mateo, Calif.   Business: Inflammation   Date completed: 11/21/13   Type: Venture financing   Raised: $17 million   Investors: Longitude Capital Management; Food Allergy Research & Education  ...
01:24 , Nov 22, 2013 |  BC Extra  |  Financial News

Allergen raises $17 million in series A

Food allergy play Allergen Research Corp. (San Mateo, Calif.) raised about $17 million in a series A round led by Longitude Capital. Not-for-profit Food Allergy Research & Education also participated. Allergen is developing oral immunotherapies...